Hemogenyx Pharmaceuticals Plc carries a market capitalization of 54.68M, placing it among publicly traded companies globally.
| Market Cap | 54.68M |
| Enterprise Value | N/A |
Hemogenyx Pharmaceuticals Plc's stock has gained approximately 424.75041% over the past 52 weeks. The 50-day moving average sits at 725.77, while the 200-day moving average is 826.50.
| Beta (5Y) | N/A |
| 52-Week Price Change | 424.75041% |
| 50-Day Moving Average | 725.77 |
| 200-Day Moving Average | 826.50 |
| Average Volume (20 Days) | N/A |
Hemogenyx Pharmaceuticals Plc's most recent stock split took place on December 13, 2024 with a 400:1 split ratio.
| Last Split Date | 12/13/2024 |
| Split Ratio | 400:1 |